Japan Age Related Macular Degeneration Drug Market Report 2016

Japan Age Related Macular Degeneration Drug Market Report 2016

1 Age Related Macular Degeneration Drug Overview

1.1 Product Overview and Scope of Age Related Macular Degeneration Drug

1.2 Classification of Age Related Macular Degeneration Drug

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Age Related Macular Degeneration Drug

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 Japan Market Size Sales (Value) and Revenue (Volume) of Age Related Macular Degeneration Drug (2011-2021)

1.4.1 Japan Age Related Macular Degeneration Drug Sales and Growth Rate (2011-2021)

1.4.2 Japan Age Related Macular Degeneration Drug Revenue and Growth Rate (2011-2021)

2 Japan Age Related Macular Degeneration Drug Competition by Manufacturers

2.1 Japan Age Related Macular Degeneration Drug Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 Japan Age Related Macular Degeneration Drug Revenue and Share by Manufactures (2015 and 2016)

2.3 Japan Age Related Macular Degeneration Drug Average Price by Manufactures (2015 and 2016)

2.4 Age Related Macular Degeneration Drug Market Competitive Situation and Trends

2.4.1 Age Related Macular Degeneration Drug Market Concentration Rate

2.4.2 Age Related Macular Degeneration Drug Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 Japan Age Related Macular Degeneration Drug Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 Japan Age Related Macular Degeneration Drug Sales and Market Share by Type (2011-2016)

3.2 Japan Age Related Macular Degeneration Drug Revenue and Market Share by Type (2011-2016)

3.3 Japan Age Related Macular Degeneration Drug Price by Type (2011-2016)

3.4 Japan Age Related Macular Degeneration Drug Sales Growth Rate by Type (2011-2016)

4 Japan Age Related Macular Degeneration Drug Sales (Volume) by Application (2011-2016)

4.1 Japan Age Related Macular Degeneration Drug Sales and Market Share by Application (2011-2016)

4.2 Japan Age Related Macular Degeneration Drug Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 Japan Age Related Macular Degeneration Drug Manufacturers Profiles/Analysis

5.1 Roche/Genentech

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Age Related Macular Degeneration Drug Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Roche/Genentech Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Novartis

5.2.2 Age Related Macular Degeneration Drug Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Novartis Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Regeneron

5.3.2 Age Related Macular Degeneration Drug Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Regeneron Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Bayer

5.4.2 Age Related Macular Degeneration Drug Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Bayer Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Valeant

5.5.2 Age Related Macular Degeneration Drug Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Valeant Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Allergan

5.6.2 Age Related Macular Degeneration Drug Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Allergan Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Alimera Sciences

5.7.2 Age Related Macular Degeneration Drug Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Alimera Sciences Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Ophthotech

5.8.2 Age Related Macular Degeneration Drug Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Ophthotech Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Acucela

5.9.2 Age Related Macular Degeneration Drug Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Acucela Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Ohr Pharmaceuticals

5.10.2 Age Related Macular Degeneration Drug Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Ohr Pharmaceuticals Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

6 Age Related Macular Degeneration Drug Manufacturing Cost Analysis

6.1 Age Related Macular Degeneration Drug Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Age Related Macular Degeneration Drug

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Age Related Macular Degeneration Drug Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Age Related Macular Degeneration Drug Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 Japan Age Related Macular Degeneration Drug Market Forecast (2016-2021)

10.1 Japan Age Related Macular Degeneration Drug Sales, Revenue Forecast (2016-2021)

10.2 Japan Age Related Macular Degeneration Drug Sales Forecast by Type (2016-2021)

10.3 Japan Age Related Macular Degeneration Drug Sales Forecast by Application (2016-2021)

10.4 Age Related Macular Degeneration Drug Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of Age Related Macular Degeneration Drug

Table Classification of Age Related Macular Degeneration Drug

Figure Japan Sales Market Share of Age Related Macular Degeneration Drug by Type in 2015

Table Application of Age Related Macular Degeneration Drug

Figure Japan Sales Market Share of Age Related Macular Degeneration Drug by Application in 2015

Figure Japan Age Related Macular Degeneration Drug Sales and Growth Rate (2011-2021)

Figure Japan Age Related Macular Degeneration Drug Revenue and Growth Rate (2011-2021)

Table Japan Age Related Macular Degeneration Drug Sales of Key Manufacturers (2015 and 2016)

Table Japan Age Related Macular Degeneration Drug Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Age Related Macular Degeneration Drug Sales Share by Manufacturers

Figure 2016 Age Related Macular Degeneration Drug Sales Share by Manufacturers

Table Japan Age Related Macular Degeneration Drug Revenue by Manufacturers (2015 and 2016)

Table Japan Age Related Macular Degeneration Drug Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Japan Age Related Macular Degeneration Drug Revenue Share by Manufacturers

Table 2016 Japan Age Related Macular Degeneration Drug Revenue Share by Manufacturers

Table Japan Market Age Related Macular Degeneration Drug Average Price of Key Manufacturers (2015 and 2016)

Figure Japan Market Age Related Macular Degeneration Drug Average Price of Key Manufacturers in 2015

Figure Age Related Macular Degeneration Drug Market Share of Top 3 Manufacturers

Figure Age Related Macular Degeneration Drug Market Share of Top 5 Manufacturers

Table Japan Age Related Macular Degeneration Drug Sales by Type (2011-2016)

Table Japan Age Related Macular Degeneration Drug Sales Share by Type (2011-2016)

Figure Japan Age Related Macular Degeneration Drug Sales Market Share by Type in 2015

Table Japan Age Related Macular Degeneration Drug Revenue and Market Share by Type (2011-2016)

Table Japan Age Related Macular Degeneration Drug Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Age Related Macular Degeneration Drug by Type (2011-2016)

Table Japan Age Related Macular Degeneration Drug Price by Type (2011-2016)

Figure Japan Age Related Macular Degeneration Drug Sales Growth Rate by Type (2011-2016)

Table Japan Age Related Macular Degeneration Drug Sales by Application (2011-2016)

Table Japan Age Related Macular Degeneration Drug Sales Market Share by Application (2011-2016)

Figure Japan Age Related Macular Degeneration Drug Sales Market Share by Application in 2015

Table Japan Age Related Macular Degeneration Drug Sales Growth Rate by Application (2011-2016)

Figure Japan Age Related Macular Degeneration Drug Sales Growth Rate by Application (2011-2016)

Table Roche/Genentech Basic Information List

Table Roche/Genentech Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Roche/Genentech Age Related Macular Degeneration Drug Sales Market Share (2011-2016)

Table Novartis Basic Information List

Table Novartis Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novartis Age Related Macular Degeneration Drug Sales Market Share (2011-2016)

Table Regeneron Basic Information List

Table Regeneron Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Regeneron Age Related Macular Degeneration Drug Sales Market Share (2011-2016)

Table Bayer Basic Information List

Table Bayer Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bayer Age Related Macular Degeneration Drug Sales Market Share (2011-2016)

Table Valeant Basic Information List

Table Valeant Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Valeant Age Related Macular Degeneration Drug Sales Market Share (2011-2016)

Table Allergan Basic Information List

Table Allergan Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Allergan Age Related Macular Degeneration Drug Sales Market Share (2011-2016)

Table Alimera Sciences Basic Information List

Table Alimera Sciences Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Alimera Sciences Age Related Macular Degeneration Drug Sales Market Share (2011-2016)

Table Ophthotech Basic Information List

Table Ophthotech Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Ophthotech Age Related Macular Degeneration Drug Sales Market Share (2011-2016)

Table Acucela Basic Information List

Table Acucela Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Acucela Age Related Macular Degeneration Drug Sales Market Share (2011-2016)

Table Ohr Pharmaceuticals Basic Information List

Table Ohr Pharmaceuticals Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Ohr Pharmaceuticals Age Related Macular Degeneration Drug Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Age Related Macular Degeneration Drug

Figure Manufacturing Process Analysis of Age Related Macular Degeneration Drug

Figure Age Related Macular Degeneration Drug Industrial Chain Analysis

Table Raw Materials Sources of Age Related Macular Degeneration Drug Major Manufacturers in 2015

Table Major Buyers of Age Related Macular Degeneration Drug

Table Distributors/Traders List

Figure Japan Age Related Macular Degeneration Drug Production and Growth Rate Forecast (2016-2021)

Figure Japan Age Related Macular Degeneration Drug Revenue and Growth Rate Forecast (2016-2021)

Table Japan Age Related Macular Degeneration Drug Production Forecast by Type (2016-2021)

Table Japan Age Related Macular Degeneration Drug Consumption Forecast by Application (2016-2021)